Immunovant (IMVT) Debt to Equity (2019 - 2023)

Immunovant (IMVT) reported Debt to Equity of $0.0 for Q1 2023, up 165.28% on a YoY basis from $0.0 in Q1 2022, and up 165.28% quarter-over-quarter from $0.0 in Q1 2022.

Immunovant (IMVT) Debt to Equity (2019 - 2023) Analysis & Trends

Immunovant has reported Debt to Equity for 4 years, with the latest figure at $0.0 in Q1 2023.

  • For the quarter ending Q1 2023, Debt to Equity rose 165.28% year-over-year to $0.0; the trailing twelve-month figure through Mar 2023 stood at $0.0 (up 165.28% YoY), and the FY2023 full-year result was $0.0, up 165.28% from the prior year.
  • Debt to Equity for Q1 2023 stood at $0.0, up from $0.0 in the prior quarter.
  • The five-year high for Debt to Equity was $0.03 in Q1 2020, with the low at -$0.41 in Q2 2019.
  • Historically, Debt to Equity has averaged -$0.05 across 4 years, with a median of $0.0 in 2023.
  • The largest YoY upside for Debt to Equity was 329.09% in 2020 against a maximum downside of 100.28% in 2020.
  • Immunovant's Debt to Equity stood at $0.03 in 2019, then slumped by 98.91% to $0.0 in 2020, then increased by 19.08% to $0.0 in 2022, then soared by 165.28% to $0.0 in 2023.
  • The last three Debt to Equity figures came in at $0.0 (Q1 2023), $0.0 (Q1 2022), and $0.0 (Q3 2020), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 0.32
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn -
9 Abivax 91.71 Bn 91.71 Bn - -
10 Immunovant 5.71 Bn 5.71 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2023 0.00
Mar 31, 2022 0.00
Sep 30, 2020 0.00
Jun 30, 2020 0.00
Mar 31, 2020 0.03
Dec 31, 2019 0.03
Sep 30, 2019 -0.11
Jun 30, 2019 -0.41
Mar 31, 2019 0.01